PHOSPHORIC ACID

PHOSPHORIC ACID was reported 541 times

PHOSPHORIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SKIN CANDIDA 33 0.0632
1 MULTIPLE DRUG THERAPY 30 0.0398
2 SEDATION COMPLICATION 93 0.0364
3 CREATININE RENAL CLEARANCE INCREASED 25 0.0334
4 CREATININE RENAL CLEARANCE DECREASED 105 0.0262
5 CEREBRAL CONGESTION 4 0.0238
6 PARATHYROID HYPERPLASIA 1 0.0179
7 HYPERPARATHYROIDISM TERTIARY 1 0.0133
8 AMINO ACID LEVEL ABNORMAL 1 0.0103
9 BLOOD CALCIUM DECREASED 105 0.0093
10 RENAL FUNCTION TEST ABNORMAL 35 0.0075
11 ORTHOSTATIC HYPOTENSION 114 0.0065
12 NEUTROPENIC SEPSIS 34 0.0048
13 ANORECTAL INFECTION 1 0.0040
14 SEDATION 94 0.0036
15 DEPRESSED LEVEL OF CONSCIOUSNESS 102 0.0026
16 HYPOMAGNESAEMIA 34 0.0024
17 BLADDER DISORDER 23 0.0023
18 COGNITIVE DISORDER 105 0.0022
19 CHONDROLYSIS 1 0.0021
20 HYPERAEMIA 4 0.0020
21 TERMINAL ILEITIS 1 0.0016
22 MOUTH ULCERATION 33 0.0016
23 MOBILITY DECREASED 111 0.0015
24 BALANCE DISORDER 130 0.0015
25 HAND DEFORMITY 19 0.0014
26 HAEMOTHORAX 4 0.0014
27 INHIBITORY DRUG INTERACTION 2 0.0013
28 MUCOSAL INFLAMMATION 33 0.0013
29 SCIATICA 20 0.0013
30 DEFORMITY 11 0.0012
31 CANDIDA INFECTION 19 0.0011
32 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
33 ANIMAL SCRATCH 1 0.0010
34 CARDIOPULMONARY FAILURE 4 0.0010
35 NERVOUS SYSTEM DISORDER 30 0.0010
36 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
37 PANCREATITIS CHRONIC 2 0.0008
38 LIP HAEMORRHAGE 1 0.0008
39 PLATELET TRANSFUSION 1 0.0008
40 HYPOKALAEMIA 34 0.0007
41 NEUTROPHIL COUNT DECREASED 30 0.0007
42 PRODUCTIVE COUGH 33 0.0007
43 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
44 CONSTIPATION 136 0.0006
45 SOFT TISSUE INFECTION 1 0.0005
46 TOXICITY TO VARIOUS AGENTS 79 0.0005
47 DEMENTIA 13 0.0005
48 HYPOTENSION 93 0.0005
49 ARTERIOSCLEROSIS 4 0.0004
50 HYPERPARATHYROIDISM SECONDARY 1 0.0004
51 ORAL CANDIDIASIS 5 0.0004
52 DRUG ABUSE 31 0.0004
53 METASTASES TO BONE 6 0.0004
54 PERIPHERAL COLDNESS 5 0.0004
55 DYSPHAGIA 33 0.0003
56 ADENOVIRUS INFECTION 1 0.0003
57 BRAIN OEDEMA 4 0.0003
58 NON-CARDIAC CHEST PAIN 1 0.0003
59 PULMONARY CONGESTION 4 0.0003
60 CYTOKINE RELEASE SYNDROME 6 0.0003
61 FALL 99 0.0003
62 GAIT DISTURBANCE 56 0.0003
63 INJECTION SITE REACTION 19 0.0003
64 BLOOD PHOSPHORUS DECREASED 1 0.0003
65 DRUG INTERACTION 43 0.0003
66 MYOCARDIAL ISCHAEMIA 3 0.0003
67 DEHYDRATION 33 0.0002
68 AORTIC DISSECTION 1 0.0002
69 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
70 PRODUCT USE IN UNAPPROVED INDICATION 57 0.0002
71 RHEUMATOID ARTHRITIS 26 0.0002
72 ANAEMIA 40 0.0002
73 RASH VESICULAR 1 0.0002
74 AGEUSIA 5 0.0002
75 APLASTIC ANAEMIA 1 0.0002
76 TREATMENT FAILURE 15 0.0002
77 PAIN 110 0.0002
78 STATUS EPILEPTICUS 2 0.0002
79 ENTEROCOLITIS 1 0.0002
80 POISONING 2 0.0002
81 DYSPNOEA 88 0.0002
82 DECREASED APPETITE 36 0.0002
83 OVERDOSE 33 0.0002
84 DEPRESSION 32 0.0001
85 HYPOPHOSPHATAEMIA 1 0.0001
86 PREMATURE DELIVERY 2 0.0001
87 HEMIPLEGIA 1 0.0001
88 BLOOD MAGNESIUM DECREASED 1 0.0001
89 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
90 HYPERCHOLESTEROLAEMIA 1 0.0001
91 WOUND INFECTION 1 0.0001
92 ASTHENIA 34 0.0001
93 PULMONARY OEDEMA 4 0.0001
94 COVID-19 PNEUMONIA 1 0.0001
95 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
96 DRUG INTOLERANCE 8 0.0001
97 HEPATIC CYTOLYSIS 1 0.0001
98 HEPATITIS 2 0.0001
99 VOMITING 36 0.0001
100 JOINT RANGE OF MOTION DECREASED 1 0.0001
101 OEDEMA 4 0.0001
102 RESPIRATORY DISTRESS 2 0.0001
103 CONDITION AGGRAVATED 22 0.0001
104 ARTHROPATHY 4 0.0001
105 HYPERTHYROIDISM 1 0.0001
106 BLOOD POTASSIUM DECREASED 2 0.0001
107 ECONOMIC PROBLEM 1 0.0001
108 OSTEOPENIA 1 0.0001
109 ILL-DEFINED DISORDER 4 0.0001
110 MUSCULOSKELETAL CHEST PAIN 1 0.0001
111 VISUAL IMPAIRMENT 8 0.0001
112 PRODUCT USE ISSUE 12 0.0001
113 CONTUSION 6 0.0001
114 COMPLETED SUICIDE 5 0.0001
115 HEADACHE 37 0.0001
116 CIRCULATORY COLLAPSE 1 0.0001
117 HYPOXIA 2 0.0001
118 DIARRHOEA 36 0.0001
119 BONE DISORDER 1 0.0001
120 END STAGE RENAL DISEASE 1 0.0001
121 OFF LABEL USE 48 0.0001
122 THROMBOCYTOPENIA 6 0.0001
123 NAUSEA 40 0.0001
124 CARDIAC FAILURE 4 0.0000
125 FULL BLOOD COUNT DECREASED 1 0.0000
126 HYPOAESTHESIA 7 0.0000
127 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
128 MUSCULAR WEAKNESS 5 0.0000
129 DEATH 37 0.0000
130 SWELLING 4 0.0000
131 ENCEPHALOPATHY 1 0.0000
132 SOMNOLENCE 8 0.0000
133 ANHEDONIA 1 0.0000
134 NEUTROPENIA 5 0.0000
135 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
136 BONE PAIN 2 0.0000
137 LABORATORY TEST ABNORMAL 1 0.0000
138 FEMUR FRACTURE 1 0.0000
139 EXPOSURE DURING PREGNANCY 2 0.0000
140 HYPOTHYROIDISM 1 0.0000
141 ALOPECIA 6 0.0000
142 STAPHYLOCOCCAL INFECTION 1 0.0000
143 VISUAL ACUITY REDUCED 1 0.0000
144 LIP SWELLING 1 0.0000
145 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
146 HYPERKALAEMIA 1 0.0000
147 ACUTE KIDNEY INJURY 4 0.0000
148 ABDOMINAL PAIN 6 0.0000
149 CHILLS 3 0.0000
150 BLINDNESS 1 0.0000
151 ERYTHEMA 5 0.0000
152 OSTEOPOROSIS 1 0.0000
153 RHABDOMYOLYSIS 1 0.0000
154 HYPOACUSIS 1 0.0000
155 MYOCARDIAL INFARCTION 4 0.0000
156 INSOMNIA 6 0.0000
157 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
158 NEPHROLITHIASIS 1 0.0000
159 DRUG INEFFECTIVE 28 0.0000
160 DISEASE RECURRENCE 1 0.0000
161 MULTIPLE SCLEROSIS 1 0.0000
162 PAIN IN EXTREMITY 6 0.0000
163 BRADYCARDIA 1 0.0000
164 PLATELET COUNT DECREASED 2 0.0000
165 CONFUSIONAL STATE 3 0.0000
166 PANCYTOPENIA 1 0.0000
167 EMOTIONAL DISTRESS 2 0.0000
168 SUICIDE ATTEMPT 1 0.0000
169 STOMATITIS 1 0.0000
170 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
171 INTENTIONAL OVERDOSE 1 0.0000
172 BLOOD CREATININE INCREASED 1 0.0000
173 INFUSION RELATED REACTION 1 0.0000
174 FEBRILE NEUTROPENIA 1 0.0000
175 INJURY 1 0.0000
176 FATIGUE 11 0.0000
177 EPISTAXIS 1 0.0000
178 HOT FLUSH 1 0.0000
179 CHRONIC KIDNEY DISEASE 1 0.0000
180 ARTHRITIS 1 0.0000
181 CARDIAC ARREST 1 0.0000
182 TREMOR 2 0.0000
183 DIZZINESS 6 0.0000
184 MALAISE 5 0.0000
185 TACHYCARDIA 1 0.0000
186 ADVERSE EVENT 1 0.0000
187 OROPHARYNGEAL PAIN 1 0.0000
188 PULMONARY EMBOLISM 1 0.0000
189 FLUSHING 1 0.0000
190 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
191 SEPSIS 1 0.0000
192 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
193 DISEASE PROGRESSION 1 0.0000
194 JOINT SWELLING 1 0.0000
195 INJECTION SITE ERYTHEMA 1 0.0000
196 RENAL FAILURE 1 0.0000
197 INFECTION 1 0.0000
198 HOSPITALISATION 1 0.0000
199 PERIPHERAL SWELLING 1 0.0000
200 URTICARIA 1 0.0000
201 COVID-19 1 0.0000
202 HYPERSENSITIVITY 1 0.0000
203 BACK PAIN 1 0.0000
204 WEIGHT DECREASED 1 0.0000
205 COUGH 1 0.0000
206 ANXIETY 1 0.0000
207 INJECTION SITE PAIN 1 0.0000
208 PNEUMONIA 1 0.0000
209 PYREXIA 1 0.0000
210 PRURITUS 1 0.0000